Are your procesess and equipment fully traceable? Learn About Chain of Compliance™
Date: August 2-6, 2019
Location: Washington, D.C.
Date: August 26-27
Location: Kansas City, MO
We’re proud to provide global support for the first-ever commercial CART-T therapies, produced by our clients Kite (Gilead) and Novartis, as well as bluebird bio’s recently approved gene therapy. We're equally proud to support more than 380 clinical trials in the regenerative medicine field across the globe.
“By 2025, we predict that the FDA will be approving 10 to 20 cell and gene therapy products a year based on an assessment of the current pipeline and the clinical success rates of these products.” – Scott Gottlieb, Former FDA Commissioner
U.S. • The Netherlands • Singapore
Sales • +1 949.232.1900 | Support • +1 949.470.2300
